» Articles » PMID: 28114969

Integrated Analysis of Hematopoietic Differentiation Outcomes and Molecular Characterization Reveals Unbiased Differentiation Capacity and Minor Transcriptional Memory in HPC/HSC-iPSCs

Overview
Publisher Biomed Central
Date 2017 Jan 25
PMID 28114969
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Transcription factor-mediated reprogramming can reset the epigenetics of somatic cells into a pluripotency compatible state. Recent studies show that induced pluripotent stem cells (iPSCs) always inherit starting cell-specific characteristics, called epigenetic memory, which may be advantageous, as directed differentiation into specific cell types is still challenging; however, it also may be unpredictable when uncontrollable differentiation occurs. In consideration of biosafety in disease modeling and personalized medicine, the availability of high-quality iPSCs which lack a biased differentiation capacity and somatic memory could be indispensable.

Methods: Herein, we evaluate the hematopoietic differentiation capacity and somatic memory state of hematopoietic progenitor and stem cell (HPC/HSC)-derived-iPSCs (HPC/HSC-iPSCs) using a previously established sequential reprogramming system.

Results: We found that HPC/HSCs are amenable to being reprogrammed into iPSCs with unbiased differentiation capacity to hematopoietic progenitors and mature hematopoietic cells. Genome-wide analyses revealed that no global epigenetic memory was detectable in HPC/HSC-iPSCs, but only a minor transcriptional memory of HPC/HSCs existed in a specific tetraploid complementation (4 N)-incompetent HPC/HSC-iPSC line. However, the observed minor transcriptional memory had no influence on the hematopoietic differentiation capacity, indicating the reprogramming of the HPC/HSCs was nearly complete. Further analysis revealed the correlation of minor transcriptional memory with the aberrant distribution of H3K27me3.

Conclusions: This work provides a comprehensive framework for obtaining high-quality iPSCs from HPC/HSCs with unbiased hematopoietic differentiation capacity and minor transcriptional memory.

Citing Articles

Epigenetic regulation and factors that influence the effect of iPSCs-derived neural stem/progenitor cells (NS/PCs) in the treatment of spinal cord injury.

Yang Y, Ma B, Chen J, Liu D, Ma J, Li B Clin Epigenetics. 2024; 16(1):30.

PMID: 38383473 PMC: 10880347. DOI: 10.1186/s13148-024-01639-5.


Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins.

Blumke A, Ijeoma E, Simon J, Wellington R, Purwaningrum M, Doulatov S Stem Cell Res Ther. 2023; 14(1):319.

PMID: 37936199 PMC: 10631132. DOI: 10.1186/s13287-023-03547-6.


Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins.

Blumke A, Ijeoma E, Simon J, Wellington R, Purwaningrum M, Doulatov S Res Sq. 2023; .

PMID: 37461708 PMC: 10350192. DOI: 10.21203/rs.3.rs-3089289/v1.


A circular RNA map for human induced pluripotent stem cells of foetal origin.

Barilani M, Cherubini A, Peli V, Polveraccio F, Bollati V, Guffanti F EBioMedicine. 2020; 57:102848.

PMID: 32574961 PMC: 7322262. DOI: 10.1016/j.ebiom.2020.102848.

References
1.
Chang G, Gao S, Hou X, Xu Z, Liu Y, Kang L . High-throughput sequencing reveals the disruption of methylation of imprinted gene in induced pluripotent stem cells. Cell Res. 2014; 24(3):293-306. PMC: 3945885. DOI: 10.1038/cr.2013.173. View

2.
Zhao X, Li W, Lv Z, Liu L, Tong M, Hai T . iPS cells produce viable mice through tetraploid complementation. Nature. 2009; 461(7260):86-90. DOI: 10.1038/nature08267. View

3.
Gao S, Zheng C, Chang G, Liu W, Kou X, Tan K . Unique features of mutations revealed by sequentially reprogrammed induced pluripotent stem cells. Nat Commun. 2015; 6:6318. DOI: 10.1038/ncomms7318. View

4.
Ohm J, Mali P, Van Neste L, Berman D, Liang L, Pandiyan K . Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Res. 2010; 70(19):7662-73. PMC: 2980296. DOI: 10.1158/0008-5472.CAN-10-1361. View

5.
Kang L, Wang J, Zhang Y, Kou Z, Gao S . iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell. 2009; 5(2):135-8. DOI: 10.1016/j.stem.2009.07.001. View